Immunocore Holdings plc
IMCR
$33.98
-$0.50-1.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.67% | 2.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.67% | 2.10% | |||
| Cost of Revenue | 17,188.71% | -99.47% | |||
| Gross Profit | -61.51% | 362.85% | |||
| SG&A Expenses | 15.96% | -11.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.64% | -4.83% | |||
| Operating Income | -141.15% | 19,575.68% | |||
| Income Before Tax | -103.87% | 184.03% | |||
| Income Tax Expenses | -2.33% | -97.89% | |||
| Earnings from Continuing Operations | -106.23% | 143.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -106.23% | 143.15% | |||
| EBIT | -141.15% | 19,575.68% | |||
| EBITDA | -123.94% | 844.66% | |||
| EPS Basic | -106.22% | 142.91% | |||
| Normalized Basic EPS | -131.00% | 172.39% | |||
| EPS Diluted | -108.00% | 141.97% | |||
| Normalized Diluted EPS | -132.35% | 169.38% | |||
| Average Basic Shares Outstanding | 0.43% | 0.57% | |||
| Average Diluted Shares Outstanding | -3.70% | 4.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||